DiamiR

Our mission is to build a leading molecular diagnostics company focused on developing minimally invasive solutions for early detection and monitoring of brain and synaptic health conditions, including mild cognitive impairment and Alzheimer’s disease, to enable earlier intervention and better planning of care. Mireskandari has over 12 years of life sciences industry experience with a focus on molecular diagnostic test development and commercialization, including regulatory and reimbursement expertise. Kumar is an accomplished research & development leader, with experience in leading CLIA facility operations. Kumar has 20+ years of experience in the development of technologies for molecular diagnostic and other applications. Kenny Ablordeppey serves as the Laboratory Supervisor and Project Manager at DiamiR. Rinder is a volunteer for the ASCP, serving on committees tasked with education and professional development, and currently is President of the ASCP, serving the pathology and laboratory professional workforce. Robert Rissman, PhD, is a Professor of Neurosciences at the University of California San Diego (UCSD), a Research Biologist at VA San Diego, Founding Director of UCSD’s Alzheimer's Disease Cooperative Study (ADCS) Biomarker Core, as well as, Founding Director of the Biomarker Core for University of Southern California (USC) Alzheimer’s Therapeutic Research Institute (ATRI) in San Diego. Mikhail Denissenko has over 20 years of experience in Diagnostics and Drug Discovery.